Vaccines Delivery Devices Market Analysis-2027

SEATTLE - Aug. 8, 2020 - PRLog -- Vaccine Delivery Devices Market Taxonomy

Vaccine delivery devices market can be segmented on the basis of product type, route of administration, end user and geography.

Vaccines are administered through subcutaneous or intramuscular routes using a syringe or needle.  Needle free technologies are one of the novel vaccine delivery technologies as they are effectively used in mass immunization programmes, thereby reducing the chances of needle stick injuries and the complications associated with the multiple use of single needle. Moreover, other vaccine delivery devices include disposable syringes, jet injectors, micro- needles, and intradermal delivery devices for delivery of inactivated poliovirus vaccine.

Increasing use of micro-needles is attributed to the demand for the painless self-administration by the patients. Vaccines delivered through micro-needles into the dermis affects faster than the intra-muscular injections, augments the market growth. However, one of the major factors restraining the market growth is the cost of the micro-needles especially in the emerging countries.

Browse Research Report: https://www.coherentmarketinsights.com/ongoing-insight/vaccines-delivery-devices-market-903
To learn more about this report, request a sample copy*

* The sample copy includes: Report Summary, Table of Contents, Segmentation, Competitive Landscape, Report Structure, Methodology.

Request a sample copy of this report: https://www.coherentmarketinsights.com/insight/request-sample/903

Innovation of hollow microstructured transdermal system, is expected to fuel the market growth

Some of the major players operating in the global vaccines delivery devices market include Panacea Pharmaceuticals, 3 M, Biojet Medical Technologies Pharmajet, Valeritas, Vaxxas, Gerresheimer, Schott AG, Corium International, and Becton Dickinson & Company. Various strategies are adopted by the key players to sustain their position in the market include product development, innovation, mergers and acquisition. For instance, 3M involved in the vaccines delivery devices market recently launched a new drug delivery device named 3M Hollow Microstructured transdermal System (hMts). This device directly delivers the vaccine to the patient's dermis, which would give rise to the stronger immune response than traditional intramuscular injections. Also, hMTS facilitate consistent and reproducible delivery of the drug. Furthermore, 3M Company has collaborated with Panacea Pharmaceuticals in administering therapeutic cancer vaccine directly to the dermis through hMTS.

Buy-Now this research report: https://www.coherentmarketinsights.com/insight/buy-now/903